137 related articles for article (PubMed ID: 11737302)
1. Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases.
Chu PG; Weiss LM
Histopathology; 2001 Nov; 39(5):455-62. PubMed ID: 11737302
[TBL] [Abstract][Full Text] [Related]
2. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
Mete O; Kilicaslan I; Gulluoglu MG; Uysal V
Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
[TBL] [Abstract][Full Text] [Related]
3. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract][Full Text] [Related]
4. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.
Leroy X; Moukassa D; Copin MC; Saint F; Mazeman E; Gosselin B
Eur Urol; 2000 Apr; 37(4):484-7. PubMed ID: 10765081
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas.
Kuroda N; Toi M; Yamamoto M; Miyazaki E; Hayashi Y; Hiroi M; Shuin T; Enzan H
Histol Histopathol; 2004 Jan; 19(1):23-8. PubMed ID: 14702167
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
7. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies.
Liu J; Fanning CV
Cancer; 2001 Dec; 93(6):390-7. PubMed ID: 11748579
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma.
Mathers ME; Pollock AM; Marsh C; O'Donnell M
Histopathology; 2002 Jun; 40(6):563-7. PubMed ID: 12047768
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 14 expression in epithelial neoplasms: a survey of 435 cases with emphasis on its value in differentiating squamous cell carcinomas from other epithelial tumours.
Chu PG; Lyda MH; Weiss LM
Histopathology; 2001 Jul; 39(1):9-16. PubMed ID: 11454039
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
[TBL] [Abstract][Full Text] [Related]
12. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?
Trpkov K; Williamson SR; Gao Y; Martinek P; Cheng L; Sangoi AR; Yilmaz A; Wang C; San Miguel Fraile P; Perez Montiel DM; Bulimbasić S; Rogala J; Hes O
Histopathology; 2019 Aug; 75(2):174-184. PubMed ID: 30895640
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
Wu SL; Kothari P; Wheeler TM; Reese T; Connelly JH
Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
[TBL] [Abstract][Full Text] [Related]
14. Identification of oncocytic lesions of salivary glands by anti-mitochondrial immunohistochemistry.
Shintaku M; Honda T
Histopathology; 1997 Nov; 31(5):408-11. PubMed ID: 9416480
[TBL] [Abstract][Full Text] [Related]
15. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.
Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ
Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255
[TBL] [Abstract][Full Text] [Related]
16. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up.
Alderman MA; Daignault S; Wolf JS; Palapattu GS; Weizer AZ; Hafez KS; Kunju LP; Wu AJ
Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
18. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.
Langner C; Wegscheider BJ; Ratschek M; Schips L; Zigeuner R
Virchows Arch; 2004 Feb; 444(2):127-34. PubMed ID: 14727107
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
